Traditional drug development is a lengthy and expensive process, often taking over a decade and costing billions of dollars. By repurposing existing drugs, the timeline can be significantly shortened, and costs can be reduced. This approach also increases the likelihood of success since the pharmacokinetic and toxicological profiles of these drugs are already known.
